Sandra Levy
ARTICLES BY THIS AUTHOR
- 10/15/2019
Sun Pharma launches Drizalma Sprinkle
Sun Pharma’s Drizalma Sprinkle is the first and only FDA approved sprinkle formulation of delayed-release duloxetine capsules. - 10/15/2019
PQS adds 3 teams for data-focused client efforts
PQS is adding three teams to address data-centric client initiatives. - 10/15/2019
PQA hosts national forum on social determinants of health
PQA is hosting a forum next month, featuring presentations by national leaders from pharmacy, health plans, health systems and solutions providers, who are pioneering social determinants of health initiatives. - 10/14/2019
PTCB launches advanced certificate programs in 2 specialty areas
PTCB is introducing advanced Assessment-Based Certificate Programs in two specialty areas: Technician Product Verification and Medication History. - 10/14/2019
ANI launches generic Aggrenox
Aspirin and extended-release dipyridamole capsules have a market value of roughly $80 million. - 10/14/2019
Noven gets FDA green light for Secuado
Noven's transdermal patch may help to mitigate some of the challenges patients face with the management of their schizophrenia, the company said. - 10/13/2019
Akorn gets FDA nod for betamethasone dipropionate
Betamethasone dipropionate lotion (augmented), 0.05% had a market value of approximately $10 million for the 12 months ended August 2019, according to IQVIA. - 10/13/2019
Allergan shareholders approve proposed acquisition by AbbVie
Allergan's proposed acquisition by AbbVie is expected to close in early 2020. - 10/13/2019
Bartell Drugs opens new store in Seattle
Bartell Drugs' Belltown location is celebrating its grand opening Saturday, Oct. 19, with prizes, gifts, and savings. - 10/13/2019
Sun Pharma launches Cequa
Cequa is the first and only FDA approved cyclosporine treatment delivered with nanomicellar, or NCELL technology.
